Moshkal K
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Moshkal K has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Dina Shokatayeva
Department of Biotechnology, Al-Farabi Kazakh National University, 71 al-Farabi Ave., Almaty 0500040, Kazakhstan
1 shared publication - Marat A. Kalenbayev
Department of Coloproctology, City Clinical Hospital No. 7, Asfendiyarov Kazakh National Medical University, Almaty 050006, Kazakhstan
1 shared publication - Mukhit Kulmaganbetov
Science Management Department, Kazakh Eye Research Institute, Almaty 050012, Kazakhstan
1 shared publication - Nurlan Duisenov
Department of Surgery with a Course of Anaesthesiology and Reanimatology, Kazakh-Russian Medical University, Abylay Khana Street 51/53, Almaty 050004, Kazakhstan
1 shared publication - Nurlan Jainakbayev
Kazakh-Russian Medical University
1 shared publication - Nurlan Jainakbayev
Department of Surgery with a Course of Anaesthesiology and Reanimatology, Kazakh-Russian Medical University, Abylay Khana Street 51/53, Almaty 050004, Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 27 October 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (11) , 551
Collagen-Stratified Abdominal Wall Closure Combined with Subaponeurotic Platelet-Rich Plasma: Feasibility and Early Incidence of Postoperative Ventral Hernia in a Prospective, Uncontrolled Single-Centre Cohort
Background: Fascial healing depends on type I collagen, yet collagen metabolism is rarely considered when choosing an abdominal wall closure technique. Objective: to describe the early incidence of postoperative ventral hernia (PVH) after closure stratified by preoperative collagen biomarkers and combined with subaponeurotic platelet-rich plasma (PRP). Methods: Prospective single-centre cohort of 106 consecutive adults (October 2024–December 2025) undergoing elective hernia repair (n = 61) or other abdominal surgery (n = 45). Serum P1NP and CTX-I defined low (n = 35), moderate (n = 27) and high (n = 44) collagen groups. Mesh was used in all low-collagen patients, in 12 moderate-collagen patients and in no high-collagen patients; all patients received PRP. Incidence was reported with Wilson 95% confidence intervals (CIs); groups were compared with exact tests, Welch’s ANOVA and multinomial regression. Results: One PVH occurred (0.9%; 95% CI 0.2–5.2%), a recurrence after mesh repair in the low-collagen group. Upper confidence limits were 12.5% and 8.0% in the moderate- and high-collagen groups. Lower collagen category was associated with older age (OR for high vs. low 0.30 per 10 years; 95% CI 0.18–0.52) and with cardiovascular comorbidity. There were no deep infections, mesh removals or deaths. Conclusions: The protocol was feasible and early PVH was rare. Because every patient received PRP, mesh use followed the collagen group and follow-up was short, these data cannot show that either component prevents PVH; a randomised trial is needed.
- 27 October 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (11) , 551
Open AccessCollagen-Stratified Abdominal Wall Closure Combined with Subaponeurotic Platelet-Rich Plasma: Feasibility and Early Incidence of Postoperative Ventral Hernia in a Prospective, Uncontrolled Single-Centre Cohort
Background: Fascial healing depends on type I collagen, yet collagen metabolism is rarely considered when choosing an abdominal wall closure technique. Objective: to describe the early incidence of postoperative ventral hernia (PVH) after closure stratified by preoperative collagen biomarkers and combined with subaponeurotic platelet-rich plasma (PRP). Methods: Prospective single-centre cohort of 106 consecutive adults (October 2024–December 2025) undergoing elective hernia repair (n = 61) or other abdominal surgery (n = 45). Serum P1NP and CTX-I defined low (n = 35), moderate (n = 27) and high (n = 44) collagen groups. Mesh was used in all low-collagen patients, in 12 moderate-collagen patients and in no high-collagen patients; all patients received PRP. Incidence was reported with Wilson 95% confidence intervals (CIs); groups were compared with exact tests, Welch’s ANOVA and multinomial regression. Results: One PVH occurred (0.9%; 95% CI 0.2–5.2%), a recurrence after mesh repair in the low-collagen group. Upper confidence limits were 12.5% and 8.0% in the moderate- and high-collagen groups. Lower collagen category was associated with older age (OR for high vs. low 0.30 per 10 years; 95% CI 0.18–0.52) and with cardiovascular comorbidity. There were no deep infections, mesh removals or deaths. Conclusions: The protocol was feasible and early PVH was rare. Because every patient received PRP, mesh use followed the collagen group and follow-up was short, these data cannot show that either component prevents PVH; a randomised trial is needed.
- 31 December 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (4) , 34-44
CURRENT STATUS OF THE PROBLEM OF PREVENTION OF POST-NEOPLASTIC VENTRAL HERNIAS
Background. At the current stage of surgical development, the problem of prevention of postoperative ventral hernias after abdominal surgeries remains unsolved. The research aims to identify the most effective approaches to the prevention of postoperative ventral hernias and to improve surgical treatment outcomes. Methods. A systematic analysis of existing publications, scientific articles, and clinical guidelines focused on the prevention and treatment of postoperative ventral hernias after abdominal surgeries will be conducted. Special attention will be paid to studies describing various surgical plastic techniques and the application of biological materials. Results. To systematize existing methods for the prevention and treatment of postoperative ventral hernias by analyzing their effectiveness and safety. To identify the most suitable surgical techniques and materials that reduce the risk of developing postoperative ventral hernias. To highlight the need for further research in the application of biological materials and new technologies in the prevention and treatment of postoperative ventral hernias. Conclusion. New technologies and materials, such as biocompatible meshes and antimicrobial sutures, have the potential to enhance treatment outcomes. However, systematic and standardized prevention and diagnostic methods are essential for equipping surgeons to mitigate postoperative ventral hernias risk. Research on collagen status, its various types in connective tissue, and new diagnostic methods will be crucial for improving patient quality of life and reducing surgical risks.
- 31 December 2024
- Published by National Scientific Center of Surgery named after A.N. Syzganov in BULLETIN OF SURGERY IN KAZAKHSTAN
- Vol. 20 (4) , 34-44
CURRENT STATUS OF THE PROBLEM OF PREVENTION OF POST-NEOPLASTIC VENTRAL HERNIAS
Background. At the current stage of surgical development, the problem of prevention of postoperative ventral hernias after abdominal surgeries remains unsolved. The research aims to identify the most effective approaches to the prevention of postoperative ventral hernias and to improve surgical treatment outcomes. Methods. A systematic analysis of existing publications, scientific articles, and clinical guidelines focused on the prevention and treatment of postoperative ventral hernias after abdominal surgeries will be conducted. Special attention will be paid to studies describing various surgical plastic techniques and the application of biological materials. Results. To systematize existing methods for the prevention and treatment of postoperative ventral hernias by analyzing their effectiveness and safety. To identify the most suitable surgical techniques and materials that reduce the risk of developing postoperative ventral hernias. To highlight the need for further research in the application of biological materials and new technologies in the prevention and treatment of postoperative ventral hernias. Conclusion. New technologies and materials, such as biocompatible meshes and antimicrobial sutures, have the potential to enhance treatment outcomes. However, systematic and standardized prevention and diagnostic methods are essential for equipping surgeons to mitigate postoperative ventral hernias risk. Research on collagen status, its various types in connective tissue, and new diagnostic methods will be crucial for improving patient quality of life and reducing surgical risks.